Home
Scholarly Works
Canagliflozin Directly Reduces Macrophage...
Conference

Canagliflozin Directly Reduces Macrophage Inflammation via AMPK in a Mouse Model of Atherosclerosis

Authors

Day EA; Ford RJ; Lu JH; Lu R; Lally JS; Schertzer JD; Steinberg GR

Volume

32

Publisher

Elsevier

Publication Date

June 1, 2018

DOI

10.1016/j.atherosclerosissup.2018.04.354

Conference proceedings

Atherosclerosis Plus

ISSN

2667-0909

Contact the Experts team